PRT-004 · CR-2026-041
Robert Kim
Mayo Rochester · Visit 2 — Week 2 (Apr 1, 2026)
Participant details
- Full name
- Robert Kim
- Date of birth
- 1960-06-30
- Sex
- Male
- Protocol version
- v3.2
Study context
- Site
- Mayo Rochester
- Randomization
- Randomized — Arm B
- Visit schedule
- Visit 2 — Week 2 (Apr 1, 2026)
- Study title
- Phase III, Cardio-Renal Study
- Study ID
- CR-2026-041
- Sponsor
- Acme Therapeutics
Informed consent is complete.
Signed March 18, 2026 at 12:00 AM.
Audit trail becomes available for consent collected in this demo session.